JMJersey Heitor da Silva Maués

Jersey Heitor da Silva Maués

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jersey Heitor da Silva Maués has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integrated Genomic and Transcriptomic Profiling of Isolated Trisomies in AML Reveals Cell Cycle Dysregulation and Therapeutic Vulnerabilities

    by Jersey Heitor da S. Maués, Bruno Kosa L. Duarte, Maria Carolina C. M. Svidnicki, Herton Luiz A. S. Filho, Fernanda Soares Niemann, Adriana da Silva S. Duarte, Paula de Melo Campos, Pedro M. Moraes‐Vieira, Sara Teresinha Olalla Saad

    Acute myeloid leukaemia (AML) with isolated trisomies (ITs) represents a distinct cytogenetic subgroup with heterogeneous clinical behaviour and incompletely defined molecular features. To explore its genomic and transcriptomic landscape, we performed next‐generation sequencing (NGS) on 14 AML patients harbouring isolated trisomies of chromosomes 8, 9, 10, 13, 14, 21 and 22. RNA sequencing (RNA‐Seq) was conducted on 15 samples, including 12 with IT and 3 cytogenetically normal AML cases (normal karyotype, NK‐AML) serving as controls. Trisomy 8 was most frequent, followed by chromosomes 13, 14 and 21. Recurrent mutations were identified in epigenetic regulators ( DNMT3A , IDH1/2 , ASXL1 , TET2 ). Transcriptomic profiling stratified cases into IT‐8, IT‐21 and IT‐13+22 subgroups. Gene set enrichment analysis (GSEA) revealed shared downregulation of cell cycle‐related pathways (e.g., G2M checkpoint) and subgroup‐specific patterns: oxidative stress and unfolded protein response in IT‐8; epithelial‐mesenchymal transition and oxidative phosphorylation in IT‐21; inflammatory signalling (IL‐6/JAK/STAT, TNF‐α/NF‐κB) in IT‐13+22. A core set of 60 differentially expressed genes (DEGs) was shared, with nine hub genes related to cell cycle ( MCM4 , CDC7 , CDC25A , DHFR ), proteostasis ( HSPA5 , DNAJC3 , CALR , HSP90B1 ) and inflammation. Drug sensitivity profiling revealed subgroup‐specific vulnerabilities: IT‐8 to DNA damage checkpoint inhibitors, IT‐21 to PLK/mTOR inhibitors and IT‐13+22 to BRAF/EGFR‐targeted agents. These findings highlight AML‐IT heterogeneity and therapeutic potential.

  • Open Access

    Investigation of BMP6 mutations in Brazilian patients with iron overload

    by Ana Carolina Mourão Toreli, Isabella Toni, Dulcinéia Martins de Albuquerque, Carolina Lanaro, Jersey Heitor Maues, Kleber Yotsumoto Fertrin, Paula de Melo Campos, Fernando Ferreira Costa


  • Omics profile of iPSC-derived astrocytes from Progressive Supranuclear Palsy (PSP) patients

    by Felipe G. Ravagnani, Hellen P. Valerio, Jersey H.S. Maués, Arthur N. de Oliveira, Renato D. Puga, Karina Griesi-Oliveira, Fabíola R. Picosse, Henrique B. Ferraz, Rodrigo R. Catharino, Graziella E. Ronsein, et al.


  • Open Access

    Role of miRNAs in Human T Cell Leukemia Virus Type 1 Induced T Cell Leukemia: A Literature Review and Bioinformatics Approach

    by Caio Bezerra Machado, Leidivan Sousa da Cunha, Jersey Heitor da Silva Maués, Flávia Melo Cunha de Pinho Pessoa, Marcelo Braga de Oliveira, Rodrigo Monteiro Ribeiro, Germison Silva Lopes, Manoel Odorico de Moraes Filho, Maria Elisabete Amaral de Moraes, André Salim Khayat, et al.

    Human T cell leukemia virus type 1 (HTLV-1) was identified as the first pathogenic human retrovirus and is estimated to infect 5 to 10 million individuals worldwide. Unlike other retroviruses, there is no effective therapy to prevent the onset of the most alarming diseases caused by HTLV-1, and the more severe cases manifest as the malignant phenotype of adult T cell leukemia (ATL). MicroRNA (miRNA) dysfunction is a common feature of leukemogenesis, and it is no different in ATL cases. Therefore, we sought to analyze studies that reported deregulated miRNA expression in HTLV-1 infected cells and patients’ samples to understand how this deregulation could induce malignancy. Through in silico analysis, we identified 12 miRNAs that stood out in the prediction of targets, and we performed functional annotation of the genes linked to these 12 miRNAs that appeared to have a major biological interaction. A total of 90 genes were enriched in 14 KEGG pathways with significant values, including TP53, WNT, MAPK, TGF-β, and Ras signaling pathways. These miRNAs and gene interactions are discussed in further detail for elucidation of how they may act as probable drivers for ATL onset, and while our data provide solid starting points for comprehension of miRNAs’ roles in HTLV-1 infection, continuous effort in oncologic research is still needed to improve our understanding of HTLV-1 induced leukemia.


  • Open Access

    MicroRNA 320a and Membrane Antigens as Tools to Evaluate the Pathophysiology of Platelets Stored in Blood Banks

    by Priscilla Cristina Moura Vieira, Jersey Heitor da Silva Maués, Letícia Martins Lamarão, Caroline Aquino Moreira-Nunes, Rommel Mário Rodríguez Burbano

    Our research group, through the analysis of miRNomes in platelet concentrates (PCs) stored in blood banks, identified and validated the miR-127 and miR-320a miRNAs as biomarkers of platelet storage lesions (PSLs) in PCs. In order to validate the miRNAs 127 and 320a methodologically, as PSL biomarkers in a large number of PC bags, we also evaluated important immunological markers involved in the platelet activation/aggregation process—the CD62P receptor (P-selectin), the surface glycoproteins (GP) IIb/IIIa, and the purinergic P2Y12 receptor—via flow cytometry. The miRNAs miR-127 and miR-320a were quantified by real-time quantitative PCR (RT-qPCR). To carry out this study, 500 collection tubes were used at the upper edge of the PC bags containing platelets. Each tube was divided into seven equal parts (totaling 3500 samples) for platelet analysis from 7 different storage days, where the 1st day represents the high-quality control, and the 7th day corresponds to the low-quality control of the platelets. After analyzing all parameters during storage days, it was concluded that the relative quantification of miR-320a below 0.50 and the CD62P receptor below 27.92% are reliable indicators of the absence of storage lesions in blood banks. We believe that the values found in the expression of the CD62P receptor legitimize the use of the miR-320a and miR-127 miRNAs to build a kit capable of accurately measuring whether the stored platelets are suitable for transfusion.


  • Open Access

    Detection of Sepsis in Platelets Using MicroRNAs and Membrane Antigens

    by Priscilla Cristina Moura Vieira Corrêa, Débora Monteiro Carneiro, Luciana Do Socorro da Silva Valente, Fabíola Marques Diogo, Leticia Martins Lamarão, Jersey Heitor da Silva Maués, Caroline Aquino Moreira-Nunes, Rommel Mario Rodríguez Burbano

    The present study proposes to legitimize in sepsis a characteristic found in platelets that suffer storage lesions in blood banks, which is the increased expression of miRNA miR-320a in relation to miR-127. Under physiologically normal conditions, an inverse relationship is observed. The aim of this study was to verify whether the analysis of miR-320a and miR-127 expression in platelets could detect a decrease in their viability and function due to the presence of pathogens in the blood of patients hospitalized in the Intensive Care Unit. We also investigated the expression of membrane antigens sensitive to platelet activation. Of the 200 patients analyzed, only those who developed sepsis (140) were found to have a higher relative quantity of miR-320a than that of miR-127. This characteristic and the increased expression of membrane antigens P2Y12, CD62P, CD41, and CD61 showed a significant association (p < 0.01) with all types of sepsis evaluated in this study. Additionally, 40% of patients hospitalized for sepsis had negative results for the first cultures. We conclude that analysis of miR-127 and miR-320a expression combined with membrane antigens evaluation, in association with the available clinical and diagnostic parameters, are important tools to detect the onset of sepsis.


  • Open Access

    Telomerase (hTERT) Overexpression Reveals a Promising Prognostic Biomarker and Therapeutical Target in Different Clinical Subtypes of Pediatric Acute Lymphoblastic Leukaemia

    by Beatriz Maria Dias Nogueira, Laudreísa da Costa Pantoja, Emerson Lucena da Silva, Fernando Augusto Rodrigues Mello Júnior, Eliel Barbosa Teixeira, Alayde Vieira Wanderley, Jersey Heitor da Silva Maués, Manoel Odorico de Moraes Filho, Maria Elisabete Amaral de Moraes, Raquel Carvalho Montenegro, et al.

    Acute Lymphoblastic Leukemia (ALL) is a neoplasm of the hematopoietic system defined as a clonal expansion of an abnormal lymphoid precursor cell. It mostly affects children under five years of age and is the most common tumor to afflict pediatric patients. The expression of the human telomerase gene (hTERT) in patients with ALL has been studied as a biomarker and could become a new therapeutic target. We evaluate the role of hTERT gene expression in ALL pediatric patients, through quantitative real-time PCR technique, and the possible correlation between hTERT expression and clinical variables: gender, age, white blood cells (WBC), gene fusions, and immunophenotyping. The analysis between healthy controls and ALL patients (N = 244) was statistically significant (p < 0.001), demonstrating hTERT overexpression in these patients. In comparison with the usual set of clinical variables, the data were not statistically significant (p > 0.05), indicating that hTERT is equally overexpressed among patients regardless of gender, age, gene fusions, and immunophenotyping. Moreover, patients who presented a higher hTERT expression level had a significant (p < 0.0001) lower overall survival rate. In summary, hTERT expression emerges as an important molecular pathway in leukemogenesis regardless patient’s clinical variables, thus, the data here presented pointed it as a valuable biomarker in pediatric acute lymphoblastic leukemia and a promising target for new therapeutic and prognostic measures.


  • Open Access

    Downregulated genes by silencing MYC pathway identified with RNA-SEQ analysis as potential prognostic biomarkers in gastric adenocarcinoma

    by Jersey Heitor da Silva Maués, Helem Ferreira Ribeiro, Raquel de Maria Maués Sacramento, Rafael Maia de Sousa, Raíssa Pereira de Tommaso, Bruno Dourado Kovacs Machado Costa, Paulo Cardoso Soares, Paulo Pimentel Assumpção, Caroline de Fátima Aquino Moreira-Nunes, Rommel Mário Rodriguez Burbano

    MYC overexpression is a common phenomenon in gastric carcinogenesis. In this study, we identified genes differentially expressed with a downregulated profile in gastric cancer (GC) cell lines with silenced MYC. The TTLL12, CDKN3, CDC16, PTPRA, MZT2B, UBE2T genes were validated using qRT-PCR, western blot and immunohistochemistry in tissues of 213 patients with diffuse and intestinal GC. We identified high levels of TTLL12, MZT2B, CDC16, UBE2T, associated with early and advanced stages, lymph nodes, distant metastases and risk factors such as H. pylori. Our results show that in the diffuse GC the overexpression of CDC16 and UBE2T indicate markers of poor prognosis higher than TTLL12. That is, patients with overexpression of these two genes live less than patients with overexpression of TTLL12. In the intestinal GC, patients who overexpressed CDC16 had a significantly lower survival rate than patients who overexpressed MZT2B and UBE2T, indicating in our data a worse prognostic value of CDC16 compared to the other two genes. PTPRA and CDKN3 proved to be important for assessing tumor progression in the early and advanced stages. In summary, in this study, we identified diagnostic and prognostic biomarkers of GC under the control of MYC, related to the cell cycle and the neoplastic process.


  • Open Access

    Computational Identification and Characterization of New microRNAs in Human Platelets Stored in a Blood Bank

    by Jersey Heitor da Silva Maués, Caroline de Fátima Aquino Moreira-Nunes, Rommel Mário Rodriguez Burbano

    Platelet concentrate (PC) transfusions are widely used to save the lives of patients who experience acute blood loss. MicroRNAs (miRNAs) comprise a class of molecules with a biological role which is relevant to the understanding of storage lesions in blood banks. We used a new approach to identify miRNAs in normal human platelet sRNA-Seq data from the GSE61856 repository. We identified a comprehensive miRNA expression profile, where we detected 20 of these transcripts potentially expressed in PCs stored for seven days, which had their expression levels analyzed with simulations of computational biology. Our results identified a new collection of miRNAs (miR-486-5p, miR-92a-3p, miR-103a-3p, miR-151a-3p, miR-181a-5p, and miR-221-3p) that showed a sensitivity expression pattern due to biological platelet changes during storage, confirmed by additional quantitative real-time polymerase chain reaction (qPCR) validation on 100 PC units from 500 healthy donors. We also identified that these miRNAs could transfer regulatory information on platelets, such as members of the let-7 family, by regulating the YOD1 gene, which is a deubiquitinating enzyme highly expressed in platelet hyperactivity. Our results also showed that the target genes of these miRNAs play important roles in signaling pathways, cell cycle, stress response, platelet activation and cancer. In summary, the miRNAs described in this study, have a promising application in transfusion medicine as potential biomarkers to also measure the quality and viability of the PC during storage in blood banks.


  • Establishment of Drug-resistant Cell Lines as a Model in Experimental Oncology: A Review

    by Márcia Vanessa Sales Amaral, Adrhyann Jullyanne DE Sousa Portilho, Emerson Lucena DA Silva, Lívia DE Oliveira Sales, Jersey Heitor DA Silva Maués, Maria Elisabete Amaral DE Moraes, Caroline Aquino Moreira-Nunes

    Many types of cancer are initially susceptible to chemotherapy, but during treatment, patients may develop resistance to therapy. Knowing that acquisition of drug resistance is a major clinical problem in antineoplastic treatment, the present work aimed to present, through a literature review, the development of chemoresistant cells lines as a model in experimental oncology. A total of 110 drug-resistant cell lines, mainly from lung tumors and leukemias, have been developed. In addition, it has been observed that the drugs used for induction of resistance represented the drugs used for first-line treatment of each neoplasia, since the ideal chemotherapeutic treatment to induce resistance in vitro aims at a better modulation of the therapeutic response in order to better study the mechanisms of resistance.